Chinese expert consensus on drug-coated balloon for the treatment of symptomatic intracranial atherosclerotic stenosis
Neurointerventional Professional Committee of Chinese Congress
Chinese College of Interventionalists
Interventional Neuroradiology Branch of Chinese Stroke Association
Li Tianxiao
Jiao Liqun
Miao Zhongrong
Liu Jianmin
Abstract：Endovascular interventional angioplasty is an important treatment for symptomatic intracranial atherosclerotic stenosis(sICAS).However,conventional endovascular interventions,such as bare-metal stenting and plain balloon angioplasty,are associated with a high risk of restenosis.Drug-coated balloon(DCB),due to the drug-carrying properties,may reduce the long-term restenosis risk and represent a novel option for the endovascular intervention of sICAS.Presently,DCB for sICAS has been a subject of increasing clinical studies,and its clinical application has progressed to small-scale use.Nevertheless,it's lack of an unified guidelines or consensus to standardize its procedural indications,technical details,and perioperative management.This expert consensus summarized the relevant clinical studies on DCB for sICAS and incorporated the practical experience of specialists from neurointerventional field,aiming to provide reasonable guidance for the current clinical use of DCB in treating sICAS.
Keywords：Drug-coated balloonSymptomatic intracranial atherosclerotic stenosisIschemic strokeEndovascular interventional angioplastyConsensus
Publication Date：2025-11-18
Online Publishing Date：2025-12-02(First online date of this platform, not the publication date of the document)
Pages：11( 794-804 )